Nibaldo C Inestrosa Selected Research

Proteins (Proteins, Gene)

1/2022	Menopause and development of Alzheimer's disease: Roles of neural glucose metabolism and Wnt signaling.
1/2018	APP/Go protein Gβγ-complex signaling mediates Aβ degeneration and cognitive impairment in Alzheimer's disease models.
1/2017	Emerging Synaptic Molecules as Candidates in the Etiology of Neurological Disorders.
4/2015	Teneurins and Alzheimer's disease: a suggestive role for a unique family of proteins.
1/2015	Alzheimer's Disease-Related Protein Expression in the Retina of Octodon degus.
12/2014	Role of Sirt1 during the ageing process: relevance to protection of synapses in the brain.
1/2013	Peroxisome proliferators reduce spatial memory impairment, synaptic failure, and neurodegeneration in brains of a double transgenic mice model of Alzheimer's disease.
12/2009	Calcium/calmodulin-dependent protein kinase type IV is a target gene of the Wnt/beta-catenin signaling pathway.
5/2009	Overexpression of amyloid precursor protein increases copper content in HEK293 cells.
9/2008	Release of acetylcholinesterase (AChE) from beta-amyloid plaques assemblies improves the spatial memory impairments in APP-transgenic mice.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nibaldo C Inestrosa Research Topics

Disease

90	Alzheimer Disease (Alzheimer's Disease) 12/2022 - 04/2002
34	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 03/2003
25	Amyloid Plaque 01/2022 - 04/2002
13	Cognitive Dysfunction 01/2022 - 01/2005
8	Dementia (Dementias) 12/2022 - 12/2004
6	Neuroinflammatory Diseases 12/2022 - 01/2013
6	Nervous System Diseases (Neurological Disorders) 04/2019 - 01/2013
6	Prion Diseases (Transmissible Spongiform Encephalopathies) 01/2006 - 03/2003
5	Neoplasms (Cancer) 01/2021 - 03/2016
4	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2023 - 05/2016
4	Gliosis 02/2020 - 06/2004
4	Memory Disorders (Memory Loss) 12/2017 - 08/2012
3	Mitochondrial Diseases (Mitochondrial Disease) 11/2017 - 01/2013
3	Inflammation (Inflammations) 01/2017 - 03/2014
3	Fibrosis (Cirrhosis) 01/2016 - 01/2015
3	Inclusion Body Myositis 01/2015 - 01/2009
2	Heart Failure 01/2022 - 12/2021
2	Prostatic Neoplasms (Prostate Cancer) 01/2021 - 01/2019
2	Obesity 04/2019 - 10/2014
2	Carcinogenesis 01/2019 - 01/2015
2	Bipolar Disorder (Manic Depressive Psychosis) 03/2016 - 02/2016
2	Central Nervous System Lupus Vasculitis 06/2015 - 01/2015
2	Hypertension (High Blood Pressure) 01/2015 - 10/2014
2	Neuroblastoma 09/2008 - 10/2003
1	Mood Disorders (Mood Disorder) 08/2022
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2022
1	Vascular Diseases (Vascular Disease) 12/2021
1	Cardiac Arrhythmias (Arrythmia) 12/2021
1	Neoplasm Metastasis (Metastasis) 01/2021
1	Autistic Disorder (Autism) 01/2021
1	Attention Deficit Disorder with Hyperactivity (Attention Deficit Hyperactivity Disorder) 01/2021
1	Neurocognitive Disorders (Clerambault Syndrome) 01/2021
1	Parkinson Disease (Parkinson's Disease) 02/2019
1	Pathologic Processes 01/2019

Drug/Important Bio-Agent (IBA)

48	Amyloid (Amyloid Fibrils)IBA 12/2022 - 04/2002
26	Peptides (Polypeptides)IBA 01/2021 - 12/2005
24	Amyloid beta-PeptidesIBA 01/2020 - 04/2002
18	Proteins (Proteins, Gene)FDA Link 01/2022 - 07/2002
13	Glucose (Dextrose)FDA LinkGeneric 08/2022 - 10/2014
10	AcetylcholinesteraseIBA 01/2013 - 04/2002
7	Cholinergic Agents (Cholinergics)IBA 03/2015 - 12/2003
6	tau Proteins (tau Protein)IBA 12/2022 - 08/2012
6	CateninsIBA 01/2021 - 01/2013
6	EnzymesIBA 01/2019 - 01/2004
6	CopperIBA 07/2011 - 10/2002
6	Prion ProteinsIBA 01/2006 - 03/2003
5	andrographolideIBA 11/2021 - 12/2014
5	FructoseIBA 01/2021 - 10/2014
5	LigandsIBA 01/2019 - 05/2007
5	hyperforinIBA 02/2016 - 03/2010
4	LithiumIBA 08/2022 - 11/2008
4	Transcription Factors (Transcription Factor)IBA 12/2017 - 06/2010
4	beta CateninIBA 06/2010 - 07/2005
3	PotassiumIBA 01/2022 - 12/2015
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 01/2005
3	Neuroprotective AgentsIBA 01/2019 - 12/2014
3	MetalsIBA 01/2017 - 01/2006
3	Phosphotransferases (Kinase)IBA 10/2016 - 12/2009
3	Glial Fibrillary Acidic ProteinIBA 12/2015 - 10/2003
3	Protein Isoforms (Isoforms)IBA 01/2006 - 01/2006
2	ResistinIBA 01/2023 - 04/2019
2	AdiponectinIBA 01/2023 - 04/2019
2	Oxygen (Dioxygen)IBA 12/2022 - 01/2014
2	CytokinesIBA 12/2022 - 01/2017
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2021 - 01/2011
2	Methionine (L-Methionine)FDA Link 02/2020 - 11/2015
2	Interleukin-6 (Interleukin 6)IBA 02/2020 - 12/2015
2	CalciumIBA 11/2016 - 01/2013
2	Imatinib Mesylate (Gleevec)FDA Link 10/2016 - 09/2008
2	MicroRNAs (MicroRNA)IBA 05/2016 - 01/2015
2	rheinIBA 01/2016 - 03/2014
2	Peroxisome ProliferatorsIBA 01/2016 - 01/2013
2	Anti-ribosomal P protein autoantibodiesIBA 06/2015 - 01/2015
2	AntigensIBA 06/2015 - 01/2015
2	Angiotensin IIIBA 02/2015 - 01/2015
2	Wnt ProteinsIBA 12/2013 - 06/2013
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 12/2013 - 01/2013
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2013 - 03/2003
2	Caspase 3 (Caspase-3)IBA 01/2013 - 09/2008
2	Cholinesterase Inhibitors (Anticholinesterases)IBA 02/2008 - 01/2004
1	NitrogenIBA 12/2022
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2022
1	InterleukinsIBA 12/2022
1	Estrogens (Estrogen)FDA Link 01/2022
1	Propranolol (Inderal)FDA LinkGeneric 12/2021
1	AlkaloidsIBA 10/2021
1	huperzine AIBA 10/2021
1	HexosesIBA 01/2021
1	Endocrine DisruptorsIBA 01/2021
1	IodineIBA 01/2021
1	perchlorateIBA 01/2021
1	Therapeutic UsesIBA 02/2020
1	Amino Acids FDA Link 02/2020
1	HomocysteineIBA 02/2020
1	AdipokinesIBA 04/2019
1	Thyroid HormonesIBA 04/2019
1	ParaquatIBA 02/2019

Therapy/Procedure

10	Therapeutics 01/2021 - 01/2006
1	Cardiac Rehabilitation 01/2022
1	Traditional Medicine (Folk Remedies) 10/2021